Chemical Structure (Zyvox 01)
Zyvox Granule, For Suspension
Product Images NDC 0009-5136
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Zyvox (NDC 0009-5136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pharmacia & Upjohn Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Zyvox 02)
This text provides dosing instructions for Linezolid, an antibiotic, in milligrams (24 e 600 mg) administered orally every 12 hours, and indicates the time frame for measuring its plasma concentration in micrograms per milliliter (yg/mL) up to 12 hours after the dose. The dots and numbers in the chart may represent the level of drug concentration at different times after a dose, although their interpretation is unclear without additional information.*
Logo (Zyvox 03)
This text appears to be a label or a distributor information of a pharmaceutical product. The product is distributed by Pharmacia & Upjohn Co, which is a division of Pfizer Inc. The address listed is in New York, NY 10017.*
Principal Display Panel (100 mL Bag Label)
This text is a label for a medication called ZYVOX. It provides instructions on how to check for leaks and ensure sterility, as well as information on dosage and storage. The medication is administered intravenously and should not be used if leaks are found. It is distributed by a company called Pharmacia & Upjohn and should not be used in series connections or with supplementary medication.*
Principal Display Panel (100 mL Bag Overwrap Label)
ZYVOX is an injection medication with 200mg of linezolid and 50.24 mg of dextrose. It is stored between 15-30°C, and each single-dose container of 100mL contains 2mg/mL of Linezolid. The medication is sterile, nonpyrogenic, and requires intravenous administration. The accompanying prescribing information should be checked before using. The infusion bags and ports do not contain natural rubber latex, and the medication itself is sensitive to light. Unused portions should be discarded, and the medication should not be used in series connections. The manufacturer is Pharmacia & Upjohn Co Division of Pfizer Inc, NY, NY 10017.*
Principal Display Panel (100 mL Bag Box Label)
This is a description of a medication containing the drug linezolid in the form of an injection. The medication is distributed by URIOLNIDIVISION and contains 10 bags of 100 mL each. The drug concentration is 200 mg/100mL (2 mg/mL). It is RX only and should be stored at 25°C (77°F) with excursions permitted to 15-30°C (59-86°F). The unused portion of the medication should be discarded. The infusion bags and ports are not made with natural rubber latex. There is information about lot number, expiry date, and quantity.*
Principal Display Panel (300 mL Bag Label)
ZYVOX is an injection medication containing linezolid used for intravenous administration. Each 300 mL container contains 600mg of the medication. It is recommended to store the medication at room temperature, not to add other medication to the container and not to use in series connections. The medication should be checked for leaks before use; if leaks are found, discard the container. The medication may exhibit a yellow color that intensifies over time, but it does not affect potency. Dosage and usage information can be found in the prescribing information that accompanies the medication. The medication is distributed by Pfizer Inc, NY.*
Principal Display Panel (300 mL Bag Overwrap Label)
Principal Display Panel (300 mL Bag Box Label)
This is a product description for linezolid injection, which is a medication that comes in a bag. The bag has 300 mL and contains 600 mg of the medication. The medication should be stored at a temperature range of 15°C to 30°C, and should not be frozen. The product comes with a lot number, expiration date, and a warning not to use it if the packaging has latex in it.*
Principal Display Panel (150 mL Bottle Label)
Principal Display Panel (150 mL Bottle Carton)
ZYVOoxX is an oral suspension containing 100 mg/5 mL of linezolid. The product comes in a 150 mL bottle to be constituted with water. The constituted product can be used for 21 days and should be stored at room temperature. The accompanying prescribing information should be consulted for dosage and use. The bottle should be gently shaken before use and protected from light and moisture. Unused or expired suspension should be discarded after 21 days. The product is manufactured in Singapore by Pharmacia & Upjohn Co.*
Principal Display Panel (600 mg Tablet Bottle Label)
This is a description of the medication Zyvox (linezolid) tablets. The tablets should be stored in a tight, child-resistant container at 25°C (77°F) and kept protected from light. Excursions are permitted to 16-30°C (50-86°F). Each tablet contains 600 mg linezolid. Additional information, including dosage and usage instructions, can be found in the accompanying prescribing information. The tablets are distributed by Pharmacia & Upjohn Co, a division of Pfizer Inc. They are made in Singapore and come in a bottle of 20 tablets that are available only with a prescription.*
Principal Display Panel (600 mg Tablet Blister Pack)
Principal Display Panel (600 mg Tablet Blister Pack Carton)
Zyvox is a prescription medicine used for in-hospital treatment. It is available in the form of 30 tablets of 600mg each. The medicine should be stored at a temperature between 16-30°C (69-86°F) and should be protected from light. The distribution of the medicine is done by Pharmacia & Upjohn Co, a division of Pfizer Inc, NY, NY 10017. The dosage and usage information have to be obtained from accompanying prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
